Switch to: Citations

Add references

You must login to add references.
  1. Does the Pharmaceutical Sector Have a Coresponsibility for the Human Right to Health?Doris Schroeder - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):298-308.
    The highest attainable standard of health is a fundamental human right, which has been part of international law since 1948. States and their institutions are the primary duty bearers responsible for ensuring that human rights are respected, protected, and fulfilled. However, more recently it has been argued that pharmaceutical companies have a coresponsibility to fulfill the human right to health. Most prominently, this coresponsibility has been expressed in the United Nations Millennium Goal 8 Target 4. “In cooperation with pharmaceutical companies, (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Montréal Statement on the Human Right to Essential Medicines.Thomas Pogge - 2007 - Cambridge Quarterly of Healthcare Ethics 16 (1):97-108.
    On September 30–October 2, 2005, a group of individuals drawn from civil society organizations, governments, international agencies, and academic institutions came together in Montréal, Québec, Canada, for an international workshop entitled “Human Rights and Access to Essential Medicines: The Way Forward.” At the conclusion of the workshop, we drafted the “Montréal Statement on the Human Right to Essential Medicines.” This “Statement” is reprinted at the end of this comment, which offers some background on the problem addressed at the workshop.
    Download  
     
    Export citation  
     
    Bookmark   11 citations  
  • The Health Impact Fund: Boosting Pharmaceutical Innovation Without Obstructing Free Access.Thomas Pogge - 2009 - Cambridge Quarterly of Healthcare Ethics 18 (1):78.
    In an earlier piece in these pages, I described the health effects of the still massive problem of global poverty: The poor worldwide face greater environmental hazards than the rest of us, from contaminated water, filth, pollution, worms, and insects. They are exposed to greater dangers from people around them, through traffic, crime, communicable diseases, sexual violence, and potential exploitation by the more affluent. They lack means to protect themselves and their families against such hazards, through clean water, nutritious food, (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Access to Healthcare and the Pharmaceutical Sector.Klaus M. Leisinger & Karin M. Schmitt - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):309-325.
    Health is higher on the international agenda than ever before, and improving the health of poor people is a central issue in development. Poor people suffer from far higher levels of ill health, mortality, and malnutrition than do those better off, and their inadequate health is one of the factors keeping them poor or for their being poor in the first place. Health is a crucially important economic asset, particularly for poor people. Their livelihoods depend on it. When poor people (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations